In this episode recorded live at Longevity Fest 2025, hosts Dr. Lexi Gonzales and Dr. Chris D'Adamo are joined by Dr. Jocelyn Strand, Director of Clinical Education and Research at Biocidin Botanicals. The discussion centers on the pervasive role of biofilms in chronic illness and immune resilience. Dr. Strand explains why biofilms act as an "invisibility cloak" against the immune system and details how botanical solutions can disrupt these structures without disrupting the delicate balance of the microbiome.
Key Discussion Points
Defining Biofilms: Biofilms are protective matrices created by microorganisms (both beneficial and pathogenic) to shield themselves from the environment. The most common visible example is the "fuzzy" feeling on teeth.
The Resistance Factor: Pathogens hidden within a biofilm can be up to 5,000x more resistant to antibiotics than free-floating organisms. This renders the immune system ineffective, leading to chronic inflammation rather than pathogen clearance.
The Oral-Gut Connection: The mouth is a primary source of gut inoculation. Humans swallow approximately one liter of saliva daily, meaning oral biofilms (like Candida or Fusobacterium) can easily translocate to the gut and cause systemic disease.
Botanical "Intelligence": Unlike pharmaceuticals that act like "napalm" to wipe out all bacteria, botanicals like Biocidin offer a synergistic approach. They disrupt biofilms and reduce pathogen load while preserving beneficial probiotic abundance.
Upcoming Research: Dr. D'Adamo and Dr. Strand discuss a new study analyzing the effects of Biocidin liquid on oral biofilms, utilizing a novel method of scraping teeth and gums rather than standard salivary testing.
Actionable Insights for Practitioners
Suspect Biofilms in Refractory Cases: If a patient improves on antimicrobials but relapses shortly after stopping, this is a hallmark sign of biofilm involvement. The pathogens are hiding, not being eliminated.
Start "Low and Slow": When introducing biofilm disruptors, start with a single drop of liquid to gauge sensitivity. This is critical for patients with high toxic loads (Lyme, mold) to avoid severe Herxheimer (die-off) reactions.
Treat the "Whole Tube": Use liquid formulations rather than capsules when possible. Swishing the liquid treats the oral microbiome first before it is swallowed to treat the gut, addressing the source of inoculation.
Integrate into the 5R Protocol: Biofilm disruptors fit firmly into the "Remove" phase of the functional medicine 5R protocol to ensure pathogens are actually accessible to the treatment.
Look for "Mystery" Patterns: Patients with "mystery illnesses" or those who experience health in waves (feeling better, then worse) likely have a biofilm component triggering intermittent inflammatory responses.
Featured Resources & Calls to Action
Product: Biocidin – A botanical combination for biofilm disruption and microbiome balance.
Tool: Biofilm Questionnaire – A screening tool created in collaboration with Dr. Paul Anderson to help clinicians assess the likelihood of biofilm involvement.
Educational Hub: Biocidin Academy – Access to webinars, white papers, and protocols.
Call to Action: Visit the Innovations in Clinical Implementation home site to access the research and resources mentioned in this episode.
Analogies for Understanding
The "Invisibility Cloak": Dr. Strand describes a biofilm as an "invisibility cloak" that pathogens wrap around themselves. Because the immune system cannot "see" or reach the bugs inside, it continues to fire weapons (inflammation) at the area, causing collateral damage to human tissue without actually killing the invader.
"Napalm" vs. Restoration: Treating the microbiome with harsh antibiotics is compared to using "napalm"—wiping out everything, good and bad. In contrast, the botanical approach is described as restoring balance, removing the bad while leaving the beneficial ecology intact.
"Fuzzy Teeth": To help patients understand what a biofilm is, Dr. Strand points to the sensation of "fuzzy teeth" after eating sugar or not brushing. That "fuzz" is a biofilm, and it exists similarly in the gut.
Dr. Jocelyn Strand, ND, is the senior director of clinical education and research at Biocidin Botanicals®. She brings both a devotion to botanicals and a passion for science to her role. Dr. Strand monitors and participates in research, trains clinicians, and is a respected and engaging speaker. She is an avid participant in microbiome research and lectures extensively with the vision of increasing awareness about the power of natural medicine. Before joining Biocidin Botanicals® in 2019, Dr. Strand was in private practice for over a decade at Lake Superior Natural Medicine in Duluth, MN, specializing in GI system disorders, Lyme, and autoimmune conditions.
Dr. Chris D’Adamo, PhD, is an epidemiologist specializing in how modifiable lifestyle factors influence health across the lifespan and is a partner at OvationLab. He earned his Ph.D. in Epidemiology from the University of Maryland School of Medicine, where he later served as Director of Research for the Center for Integrative Medicine. As Principal Investigator, Dr. D’Adamo has led numerous clinical trials and observational studies on dietary supplements, natural products, interventional devices, micronutrients, environmental toxicants, and lifestyle-based interventions. He has authored over 100 peer-reviewed publications, contributed to medical textbooks, and lectures internationally on nutrition and integrative medicine. Dr. D’Adamo also serves as Senior Research Advisor to the Institute for Functional Medicine and sits on several scientific advisory boards.
Dr. Lexi Gonzales, ND, MS, IFMCP, is a clinician, educator, and implementation strategist working at the forefront of functional and longevity medicine. Trained in biochemistry, systems biology, and translational research, she develops practical frameworks that strengthen clinical reasoning and elevate patient care. As Senior Clinical Implementation and AI Specialist at OvationLab, she designs models and educational systems that help practitioners integrate emerging technologies with clarity and consistency. Her clinical background spans primary care within an insurance-based integrative model, multidisciplinary practice at Vida Integrated Health, and private functional medicine practice with a focus on hormonal and metabolic optimization, endometriosis, and fertility. She also served as IFM’s inaugural Medical Education Resident and later as Clinical Content Developer.